Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEVP & CFOCIK 0001814876
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 2 | Coyne Terrance P.EVP & CFO |  RPRXRoyalty Pharma plcDerivative conversion | C | — 150.0K sh | Nov 6, 2026 traded Nov 6, 2026 | |
Coyne Terrance P.EVP & CFO |
| RPRXRoyalty Pharma plc Grant or award |
| A |
| — 7,122 sh |
| Nov 6, 2026 traded Nov 4, 2026 |
| 2 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Derivative conversion | C | — 100.0K sh | Nov 6, 2026 traded Nov 6, 2026 |
| 2 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Derivative conversion | C | — 10.0K sh | Nov 6, 2026 traded Nov 6, 2026 |
| 6 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Derivative conversion | C | — 15.0K sh | Nov 6, 2026 traded Nov 6, 2026 |
| 21 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $541K 9,230 sh | Aug 17, 2026 traded Aug 13, 2026 |
| 18 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $105K 1,772 sh | Aug 17, 2026 traded Aug 13, 2026 |
| 5 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Gift | G | — 18.5K sh | Aug 7, 2026 traded Aug 7, 2026 |
| 2 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Grant or award | A | — 11.0K sh | Aug 7, 2026 traded Aug 5, 2026 |
| 1 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $93K 1,875 sh | Apr 30, 2026 traded Apr 28, 2026 |
| 19 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $1.64M 32.9K sh | Apr 30, 2026 traded Apr 28, 2026 |
| 1 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $85K 1,875 sh | Mar 25, 2026 traded Mar 23, 2026 |
| 15 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $1.50M 32.9K sh | Mar 25, 2026 traded Mar 23, 2026 |
| 14 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Grant or award | A | — 26.6K sh | Feb 13, 2026 traded Feb 11, 2026 |
| 16 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $148K 3,750 sh | Jan 23, 2026 traded Jan 20, 2026 |
| 22 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $2.59M 65.8K sh | Jan 23, 2026 traded Jan 20, 2026 |
| 18 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $121K 3,126 sh | Nov 26, 2025 traded Nov 24, 2025 |
| 11 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $24K 624 sh | Nov 26, 2025 traded Nov 24, 2025 |
| 24 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $2.13M 55.1K sh | Nov 26, 2025 traded Nov 24, 2025 |
| 17 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $406K 10.7K sh | Nov 26, 2025 traded Nov 24, 2025 |
| 23 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $2.59M 65.8K sh | Nov 19, 2025 traded Nov 17, 2025 |
| 17 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Open-market sale · 10b5-1 plan | SELL | $147K 3,750 sh | Nov 19, 2025 traded Nov 17, 2025 |
| 13 | Coyne Terrance P.EVP & CFO | RPRXRoyalty Pharma plc Grant or award | A | — 6,168 sh | Nov 7, 2025 traded Nov 5, 2025 |